Anna Morena D’Alise

Company: Nouscom

Job title: Head of Preclinical and Clinical Immunology

Seminars:

Viral Vectored Vaccines Targeting Many Neoantigens elicit effective anti-tumor T cell immunity and response in combination with anti-PD1 1:15 pm

Nouscom proprietary engineered viral vectors encoding large number of tumor neoantigens elicit strong immune response and effectively synergize with checkpoint inhibitors (CPI) to eradicate large tumors in preclinical models Effectiveness of vaccination is CD8 mediated and correlates with expansion and diversification of the intratumoral T cell repertoire Clinical development in indications with high Tumor Mutational…Read more

day: Day Two